Number of the records: 1  

Light‐activated carbon monoxide prodrugs based on bipyridyl dicarbonyl ruthenium(II) complexes

  1. 1.
    SYSNO ASEP0532238
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleLight‐activated carbon monoxide prodrugs based on bipyridyl dicarbonyl ruthenium(II) complexes
    Author(s) Geri, S. (DE)
    Krunclová, Tereza (UMCH-V) ORCID
    Janoušková, Olga (UMCH-V) RID, SAI, ORCID
    Pánek, Jiří (UMCH-V) RID, ORCID
    Hrubý, Martin (UMCH-V) RID, ORCID
    Hernández-Valdés, D. (CH)
    Probst, B. (CH)
    Alberto, R. A. (CH)
    Mamat, C. (DE)
    Kubeil, M. (DE)
    Stephan, H. (DE)
    Source TitleChemistry - A European Journal. - : Wiley - ISSN 0947-6539
    Roč. 26, č. 48, SI (2020), s. 10992-11006
    Number of pages15 s.
    Languageeng - English
    CountryDE - Germany
    Keywordscarbon monoxide ; prodrug ; light activation
    Subject RIVCD - Macromolecular Chemistry
    OECD categoryPolymer science
    R&D ProjectsGA19-01438S GA ČR - Czech Science Foundation (CSF)
    Method of publishingOpen access
    Institutional supportUMCH-V - RVO:61389013
    UT WOS000563928800001
    EID SCOPUS85089397245
    DOI10.1002/chem.202002139
    AnnotationTwo photoactivatable dicarbonyl ruthenium(II) complexes based on an amide‐functionalised bipyridine scaffold (4‐position) equipped with an alkyne functionality or a green‐fluorescent BODIPY (boron‐dipyrromethene) dye have been prepared and used to investigate their light‐induced decarbonylation. UV/Vis, FTIR and 13C NMR spectroscopies as well as gas chromatography and multivariate curve resolution alternating least‐squares analysis (MCR‐ALS) were used to elucidate the mechanism of the decarbonylation process. Release of the first CO molecule occurs very quickly, while release of the second CO molecule proceeds more slowly. In vitro studies using two cell lines A431 (human squamous carcinoma) and HEK293 (human embryonic kidney cells) have been carried out in order to characterise the anti‐proliferative and anti‐apoptotic activities. The BODIPY‐labelled compound allows for monitoring the cellular uptake, showing fast internalisation kinetics and accumulation at the endoplasmic reticulum and mitochondria.
    WorkplaceInstitute of Macromolecular Chemistry
    ContactEva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358
    Year of Publishing2021
    Electronic addresshttps://chemistry-europe.onlinelibrary.wiley.com/doi/full/10.1002/chem.202002139
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.